Ballentine Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ballentine Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,904	Closed	-$1.01M	–	521
2021 Q4	$1.01M	Buy	10,904 +329	+3%	+$21.7K	0.03%	178
2021 Q3	$629K	Buy	10,575 +2,850	+37%	+$168K	0.02%	205
2021 Q2	$527K	Sell	7,725 -53	-0.7%	-$3.46K	0.02%	226
2021 Q1	$539K	Buy	7,778 +260	+3%	+$20K	0.02%	215
2020 Q4	$577K	Buy	7,518 +12	+0.2%	+$899	0.02%	198
2020 Q3	$561K	Buy	7,506 +6	+0.1%	+$400	0.02%	197
2020 Q2	$472K	Sell	7,500 -23	-0.3%	-$1.26K	0.02%	214
2020 Q1	$316K	Buy	7,523 +23	+0.3%	+$1.05K	0.02%	241
2019 Q4	$341K	Hold	7,500	–	–	0.02%	285
2019 Q3	$343K	Hold	7,500	–	–	0.02%	264
2019 Q2	$440K	Hold	7,500	–	–	0.02%	231
2019 Q1	$336K	Hold	7,500	–	–	0.02%	232
2018 Q4	$292K	Hold	7,500	–	–	0.02%	250
2018 Q3	$345K	Buy	+7,500	New	+$304K	0.02%	247

Ballentine Partners's ARNA Position: Q1 2022 in Review

Ballentine Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 10,904 shares — an estimated $1.01M sold.

Ballentine Partners first reported a position in ARNA in Q3 2018 and held it in 14 quarters. The position peaked at $1.01M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Ballentine Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Ballentine Partners sold 10,904 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.01M.
Ballentine Partners first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 14 quarters.
Ballentine Partners's Arena Pharmaceuticals Inc position peaked at $1.01M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Ballentine Partners's 13F filing for Q1 2022, filed 5 May 2022.